TLX Ann: Phase II study for indication expansion of TLX250-CDx doses - 19th Jun 2023, 8:30am

annb0t

annb0t

Top 20
TLX Ann: Phase II study for indication expansion of TLX250-CDx doses
Price Sensitive: Y
Date: 19th Jun 2023, 8:30am

>>> Read announcement: Google: TLX Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
TLX Ann: First Patient Dosed in Phase 3 Illuccix China Study - 11th Aug 2023, 9:05am
Replies
0
Views
122
annb0t
annb0t
annb0t
TLX Ann: Investor briefing on ASCO-GU Zircon Phase III Results - 10th Feb 2023, 8:24am
Replies
0
Views
164
annb0t
annb0t
annb0t
TLX Ann: Chinese NMPA approves Phase III study of TLX591-CDx - 17th Oct 2022, 8:23am
Replies
0
Views
200
annb0t
annb0t
annb0t
TLX Ann: Chinese NMPA Approves TLX250 Phase III registration study - 28th Sep 2022, 8:18am
Replies
0
Views
193
annb0t
annb0t
annb0t
TLX Ann: ProstACT TARGET Phase II Study Ethics Approval - 12th Apr 2022, 9:28am
Replies
0
Views
295
annb0t
annb0t
Top Bottom